The UK is the first to approve a CRISPR-based gene therapy for treating sickle cell disease and beta thalassemia. But not everyone is likely to get access.

With 440,000 cases reported so far this year, chikungunya – which causes severe joint pain and can lead to debilitating arthritis – is a growing problem worldwide. Climate change is likely to make it worse.

Hybrid viruses can emerge from co-infections. And we don’t know their effects.

More than 8,000 Zimbabweans have fallen ill with the deadly bacterial illness since February, but the health system is working hard to get ahead of the growing epidemic.

Gavi’s Board, which brings together stakeholders from across the world of immunisation, will meet in Ghana this week. Its chair, Prof José Manuel Barroso, outlines the key issues that will be up for discussion and why.

New swine flu variants are worrying, but there’s no evidence of pandemic potential.

Antimicrobial resistance is one of the biggest global threats to health, food security and development. This month, The Conversation’s experts explore how we got here and the potential solutions.

Countries can now submit plans to introduce diphtheria, tetanus and pertussis (DTP)-containing vaccine boosters (DTP boosters) and the six-in-one hexavalent vaccine.

Amid climate change, vector-borne diseases are spreading at increased rates, across larger areas. West Bengal in India is battling rising rates of mosquito-transmitted dengue fever.

For the first time in 2024, climate change risk will rank among the criteria informing Gavi’s Vaccine Investment Strategy (VIS). Here’s what that means.

New generations of vaccines and nets are providing fresh hope of kickstarting stalled progress on malaria in Africa back into gear once more.